Report Categories
View AllRecent Articles
View All
NOM Nuveen latest quarterly earnings report carries no consensus comparable metrics as management reaffirms its muni portfolio strategy
The RD spending story behind Instil Bio TIL innovation Instil Bio posts 41 EPS beat narrower loss no revenue
The TJX Companies Inc XLY Wall Street Consensus Bullish on Sector Outperformance and Steady Earnings Trajectory
NOVT Novanta posts narrow Q4 2025 EPS beat with shares falling over 6 percent in todays trading session
The key risks discussed in PetMed Express PETS earnings Q1 2026 Profit Disappoints
Is Designer DBI stock strengthening its trend Q1 2026 Better Than Expected
SMTK SmartKem posts quarterly results with limited disclosure CEO highlights progress on display technology partnerships
Why Orangekloud ORKT deserves a spot on your radar now On the Radar 20260505
Kevin Warsh Federal Reserve Chair Nomination Confirmation Pathway and Market Implications
TDOC Teladoc Health shares gain 66 percent even as Q1 2026 EPS misses Wall Street analyst estimates